Portfolio Companies

Partners for long-term growth

When you partner with Sands Capital, you access the full scope of research, networks and insights across the Sands Capital platform. We use our Six Investment Criteria established almost 30 years ago to identify high-quality growth companies and fuel their businesses.

0
Team
0 +
Businesses
$ 0 B
Invested
Company
Status
Category
Partner Since
The case studies provided herein are a selection of investments that we believe illustrate our investment approach and philosophy, as well as the range of businesses in which Sands Capital typically invests. They were selected on an objective basis. The case studies are being provided for discussion purposes only and the information included should not be relied upon to make any investment decision.

The actual realizations on unrealized investments will depend on, among other factors, future operating results of the investments, the value of the underlying assets, and market conditions at the time of disposition, distribution, or initial public offering.
Genomics Logo
Status: NASDAQ: TXG
Category: Life Sciences
Partner Since: April 2022
10X Genomics
1648827780
Genomics Logo

Show details

908 devices logo black orange title
Status: NASDAQ: MASS
Category: Life Sciences
Partner Since: April 2019
908 Devices
1554133440
908 devices logo black orange title

Show details

Acessa colorful black logo title
Status: Exited
Category: Life Sciences
Partner Since: June 2017
Acessa Health
1496277217
Acessa colorful black logo title

Show details

acrivon logo
Status: NASDAQ: ACRV
Category: Life Sciences
Partner Since: November 2021
Acrivon Therapeutics
1637077680
acrivon logo

Show details

Acumen pharmaceuticals logo title
Status: NASDAQ: ABOS
Category: Life Sciences
Partner Since: November 2020
Acumen Pharmaceuticals
1604245740
Acumen pharmaceuticals logo title

Show details

Agilis logo
Status: Exited
Category: Life Sciences
Partner Since: February 2017
Agilis Bio
1485964200
Agilis logo

Show details

Anaplan logo title
Status: Exited
Category: Technology
Partner Since: May 2014
Anaplan
1398904414
Anaplan logo title

Show details

Ancora logo gray title gold
Status: Active
Category: Life Sciences
Partner Since: June 2021
Ancora Heart
1622562720
Ancora logo gray title gold

Show details

Ankyra logo
Status: Active
Category: Life Sciences
Partner Since: August 2021
Ankyra
1627819920
Ankyra logo

Show details

App dynamics title logo black
Status: Exited
Category: Technology
Partner Since: July 2014
AppDynamics
1404229920
App dynamics title logo black

Show details

Archer logo title black
Status: Acquired
Category: Life Sciences
Partner Since: December 2019
ArcherDx
1575164400
Archer logo title black

Show details

Avitide logo title color colors
Status: Exited
Category: Life Sciences
Partner Since: June 2017
Avitide
1496282520
Avitide logo title color colors

Show details

Status: Active
Category: Life Sciences
Partner Since: August 2023
Beta Bionics

Show details

BigBasket green red logo title
Status: Exited
Category: Technology
Partner Since: October 2015
BigBasket
1443664920
BigBasket green red logo title

Show details

BioSplice gray logo title
Status: Active
Category: Life Sciences
Partner Since: March 2021
BioSplice Therapeutics
1614560460
BioSplice gray logo title

Show details

Blackbuck red black title logo
Status: Active
Category: Technology
Partner Since: January 2017
BlackBuck
1483232460
Blackbuck red black title logo

Show details

bloop logo
Status: Active
Category: Technology
Partner Since: November 2021
Bloop
1635782340
bloop logo

Show details

boom logo
Status: Featured
Category: Technology
Partner Since: July 2019
Boom Entertainment
1561982520
boom logo

Show details

Brightflag logo title
Status: Active
Category: Technology
Partner Since: March 2019
Brightflag
1551402060
Brightflag logo title

Show details

Candel therapeutics logo
Status: Active
Category: Life Sciences
Partner Since: March 2019
Candel
1551402060
Candel therapeutics logo

Show details

Cincor logo
Status: NASDAQ: CINC
Category: Life Sciences
Partner Since: January 2022
CinCor Pharma
1641039240
Cincor logo

Show details

Load More
The case studies provided herein are a selection of investments that we believe illustrate our investment approach and philosophy, as well as the range of businesses in which Sands Capital typically invests. They were selected on an objective basis. The case studies are being provided for discussion purposes only and the information included should not be relied upon to make any investment decision.

The actual realizations on unrealized investments will depend on, among other factors, future operating results of the investments, the value of the underlying assets, and market conditions at the time of disposition, distribution, or initial public offering.